https://www.reuters.com/business/healthcare-pharmaceuticals/covid-vaccine-maker-novavax-reports-better-than-expected-revenue-2023-11-09/
0
0
11/9/23 at 3:32pm
Organization
Reuters
54 words
0
Comments
COVID-19 vaccine maker Novavax <a href="https://www.reuters.com/markets/companies/NVAX.O" target="_blank">(NVAX.O)</a> on Thursday beat market estimates for quarterly revenue, boosted by U.S. government grants to help cover the expense of clinical trials, and…
You are the first to view
Create an account
or login to join the discussion